Advertisement.

MYRX Projected Dividend Yield

Myrexis, Inc. ( OTCBB : MYRX )

Myrexis Inc. was a biopharmaceutical company that generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. In Feb. 2012, Co. announced that it had suspended development activity on all of Co.'s preclinical and clinical programs and retained Stifel Nicolaus Weisel, an investment banking firm, to assist in reviewing and evaluating a range of strategic alternatives to enhance shareholder value. Thereafter, in Mar. 2012, Co. initiated an alignment of Co.'s resCo.'sces involving a phased reduction in Co.'s workforce from approx. 59 employees to 1 employee as of June 30, 2013.

21 YEAR PERFORMANCE RESULTS

MYRX Dividend History Detail
MYRX Dividend News
MYRX Competitors News

# of Shares: 0

Closing Price: 0.01

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000